Bruker Features the Use of Nuclear Magnetic Resonance for Early disease detection in Educational Webinar
YORBA LINDA, Calif. (PRWEB) August 13, 2018 -- Quantification in body fluids like plasma/serum and urine is valuable because it provides information on endogenous compounds produced in the body as well as capturing drugs and their metabolites, in addition lifestyle-based molecules can be recognized, be it from nutritional habits or physical activity.
By performing Nuclear Magnetic Resonance (MNR) on body fluid samples, the role of the metabolites is identified in a multitude of conditions, like IBD, cardiovascular, obesity and diabetes. Being able to profile the metabolome and its changes over time in body fluids is particularly relevant in the clinical area as a potential diagnostic tool and in early disease detection and prevention either on a personal or population wide level.
Standardized NMR can identify metabolites in a wide concentration range in body fluids. Highly efficient analysis software provided by Bruker can quantify a multitude of small molecules in urine and plasma/serum while delivering also lipoprotein subclass information in the latter in a fully automated approach
In this webinar, which is sponsored by Bruker, viewers can expect a discussion into how new methods of determining the concentration and type of metabolites in plasma/serum and urine have distinct advantages over current conventional methods, and how this new method can be used as a large-scale screening technique. Viewers can also expect to see how metabolic research can use NMR as a leading analysis tool for body fluids.
Now NMR can be used in high throughput metabolomics screening. This webinar will discuss the robustness of standardized NMR technology, especially with regard to reproducibility and transferability.
The speakers for this event will be Prof. Elaine Holmes, professor of chemical biology at Imperial College London; and Prof. Claudio Luchinat professor of chemistry at the University of Florence.
Along with her responsibilities as a professor of chemical biology, Prof. Holmes is also the Head of the Division of Computational and Systems Medicine at Imperial College London with over 20 years of experience in metabolic research.
Prof. Luchinat is the co-founder and Director of Center of Magnetic Resonance, and of Interuniversity Consortium on Magnetic Resonance of MetalloProteins, as well as his full professorship at the University of Florence. His research interests include development of NMR-based structural methodologies, electron and nuclear relaxation, NMR of paramagnetic species, relaxometry, bioinorganic chemistry, and metabolomics.
LabRoots will host the August 30, 2018. Attendees will have two opportunities to watch live, the first session will begin at 10 a.m. CEST and a second will follow at 5 p.m. CEST. To learn more about these webinars, discover the continuing education credits available, or register for free, click here for the first session and here for the second session.
About Bruker Corporation (NASDAQ: BRKR)
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: http://www.bruker.com.
About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.
Karen Sorenson, LabRoots, Inc., http://www.LabRoots.com, +1 (619) 861-0590, [email protected]
Share this article